Phacoemulsification in Nanophthalmic Eye, a Way to Manage Glaucoma: Case Report
A rare condition called nanophthalmos causes variable degrees of vision impairment. One may present with nanophthalmos as a hereditary or sporadic condition. There have been documented cases of nanophthalmos treated with bilateral cataract extraction and intraocular lens (IOL) implantation for intra...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Case Reports in Ophthalmological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2024/2633679 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559296187990016 |
|---|---|
| author | Dania Bamefleh Konrad Schargel Valmore A. Semidey Faisal A. Altahan Edward Schargel |
| author_facet | Dania Bamefleh Konrad Schargel Valmore A. Semidey Faisal A. Altahan Edward Schargel |
| author_sort | Dania Bamefleh |
| collection | DOAJ |
| description | A rare condition called nanophthalmos causes variable degrees of vision impairment. One may present with nanophthalmos as a hereditary or sporadic condition. There have been documented cases of nanophthalmos treated with bilateral cataract extraction and intraocular lens (IOL) implantation for intractable secondary glaucoma or chronic angle-closure glaucoma. We describe a case of closed-angle glaucoma in a nanophthalmic eye with increased intraocular pressure (IOP) on full medical treatment, along with concurrent drug side effects. As a first surgical procedure, we recommend phacoemulsification of the clear lens + IOL. The challenge in treating nanophthalmic eyes lies in managing the possibility of developing glaucoma in an eye where anatomical conditions make surgery extremely risky. This must be balanced against the advantages of lessening exposure contact in the trabecular meshwork and optimizing the anterior chamber for potential future glaucoma surgery, which can improve the prognosis in these cases. Lastly, it is critical to have a thorough conversation with the patient about the aims, risks, and advantages. The patient’s understanding and expectations should also be crystal apparent. The primary objective should always be to enhance the circumstances for the most effective glaucoma therapy, not to perform refractive surgery. |
| format | Article |
| id | doaj-art-9b3fbd2352ac459086e48d3840b5e90e |
| institution | Kabale University |
| issn | 2090-6730 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Ophthalmological Medicine |
| spelling | doaj-art-9b3fbd2352ac459086e48d3840b5e90e2025-02-03T01:30:22ZengWileyCase Reports in Ophthalmological Medicine2090-67302024-01-01202410.1155/2024/2633679Phacoemulsification in Nanophthalmic Eye, a Way to Manage Glaucoma: Case ReportDania Bamefleh0Konrad Schargel1Valmore A. Semidey2Faisal A. Altahan3Edward Schargel4Glaucoma DivisionGlaucoma DivisionVitreoretinal DivisionCollege of MedicineCollege of MedicineA rare condition called nanophthalmos causes variable degrees of vision impairment. One may present with nanophthalmos as a hereditary or sporadic condition. There have been documented cases of nanophthalmos treated with bilateral cataract extraction and intraocular lens (IOL) implantation for intractable secondary glaucoma or chronic angle-closure glaucoma. We describe a case of closed-angle glaucoma in a nanophthalmic eye with increased intraocular pressure (IOP) on full medical treatment, along with concurrent drug side effects. As a first surgical procedure, we recommend phacoemulsification of the clear lens + IOL. The challenge in treating nanophthalmic eyes lies in managing the possibility of developing glaucoma in an eye where anatomical conditions make surgery extremely risky. This must be balanced against the advantages of lessening exposure contact in the trabecular meshwork and optimizing the anterior chamber for potential future glaucoma surgery, which can improve the prognosis in these cases. Lastly, it is critical to have a thorough conversation with the patient about the aims, risks, and advantages. The patient’s understanding and expectations should also be crystal apparent. The primary objective should always be to enhance the circumstances for the most effective glaucoma therapy, not to perform refractive surgery.http://dx.doi.org/10.1155/2024/2633679 |
| spellingShingle | Dania Bamefleh Konrad Schargel Valmore A. Semidey Faisal A. Altahan Edward Schargel Phacoemulsification in Nanophthalmic Eye, a Way to Manage Glaucoma: Case Report Case Reports in Ophthalmological Medicine |
| title | Phacoemulsification in Nanophthalmic Eye, a Way to Manage Glaucoma: Case Report |
| title_full | Phacoemulsification in Nanophthalmic Eye, a Way to Manage Glaucoma: Case Report |
| title_fullStr | Phacoemulsification in Nanophthalmic Eye, a Way to Manage Glaucoma: Case Report |
| title_full_unstemmed | Phacoemulsification in Nanophthalmic Eye, a Way to Manage Glaucoma: Case Report |
| title_short | Phacoemulsification in Nanophthalmic Eye, a Way to Manage Glaucoma: Case Report |
| title_sort | phacoemulsification in nanophthalmic eye a way to manage glaucoma case report |
| url | http://dx.doi.org/10.1155/2024/2633679 |
| work_keys_str_mv | AT daniabamefleh phacoemulsificationinnanophthalmiceyeawaytomanageglaucomacasereport AT konradschargel phacoemulsificationinnanophthalmiceyeawaytomanageglaucomacasereport AT valmoreasemidey phacoemulsificationinnanophthalmiceyeawaytomanageglaucomacasereport AT faisalaaltahan phacoemulsificationinnanophthalmiceyeawaytomanageglaucomacasereport AT edwardschargel phacoemulsificationinnanophthalmiceyeawaytomanageglaucomacasereport |